We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals

162 hedge funds and large institutions have $2.33B invested in Acadia Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 57 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more call options, than puts

Call options by funds: $243M | Put options by funds: $22.1M

75% more funds holding in top 10

Funds holding in top 10: 47 (+3)

20% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 20

8% more capital invested

Capital invested by funds: $2.16B → $2.33B (+$168M)

1% more funds holding

Funds holding: 160162 (+2)

12% less repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 57

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.2%
New
24
Increased
50
Reduced
57
Closed
20
Calls
$243M
Puts
$22.1M
Net Calls
+$221M
Net Calls Change
-$54.7M
Name Holding Trade Value Shares
Change
Change in
Stake
Neuberger Berman Group
176
Neuberger Berman Group
New York
-$369K -16,325 Closed
Nomura Holdings
177
Nomura Holdings
Japan
-$366K -16,291 Closed
SCM
178
Stevens Capital Management
Pennsylvania
-$253K -11,199 Closed
SB
179
Suntrust Banks
Georgia
-$236K -10,527 Closed
VFA
180
Virtus Fund Advisers
Connecticut
-$152K -6,723 Closed
Bank of Montreal
181
Bank of Montreal
Ontario, Canada
-$49K -2,160 Closed
FWM
182
Focused Wealth Management
New York
-$9K -400 Closed